Cargando…

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats

PURPOSE: To compare the levels of gadolinium in the blood, cerebrum, cerebellum, liver, femur, kidneys, and skin after multiple exposure of rats to the macrocyclic gadolinium‐based contrast agents (GBCAs) gadoterate, gadobutrol, and gadoteridol. MATERIALS AND METHODS: Fifty male Wistar Han rats were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bussi, Simona, Coppo, Alessandra, Botteron, Catherine, Fraimbault, Valérie, Fanizzi, Antonello, De Laurentiis, Elisa, Colombo Serra, Sonia, Kirchin, Miles A., Tedoldi, Fabio, Maisano, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836870/ https://www.ncbi.nlm.nih.gov/pubmed/28730643 http://dx.doi.org/10.1002/jmri.25822

Ejemplares similares

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
por: Bonafè, Roberta, et al.
Publicado: (2023)

Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats
por: Bussi, Simona, et al.
Publicado: (2021)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients
por: Lee, Ji Ye, et al.
Publicado: (2017)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats
por: Rasschaert, Marlène, et al.
Publicado: (2018)

Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast Agent
por: Lohrke, Jessica, et al.
Publicado: (2022)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents
por: Robert, Philippe, et al.
Publicado: (2015)

Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents
por: Jost, Gregor, et al.
Publicado: (2016)

Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations
por: Lattanzio, Silvia Maria, et al.
Publicado: (2020)

Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
por: Splendiani, Alessandra, et al.
Publicado: (2019)

Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review
por: Al-Muhanna, Afnan Fahd
Publicado: (2022)

Comparison of linear versus macrocyclic gadolinium chelates in rat skeletal muscle
por: Balik, Mehmet Sabri, et al.
Publicado: (2022)

Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents
por: Cao, Chun-Yan, et al.
Publicado: (2013)

Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions
por: Boyken, Janina, et al.
Publicado: (2018)

Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents
por: Strzeminska, Izabela, et al.
Publicado: (2020)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

Comparison of blood pool and extracellular gadolinium contrast for functional MR evaluation of vascular thoracic outlet syndrome
por: Lim, Ruth P, et al.
Publicado: (2013)

Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview
por: Falk Delgado, Anna, et al.
Publicado: (2019)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
por: Froehlich, Johannes M., et al.
Publicado: (2023)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity
por: Robic, Caroline, et al.
Publicado: (2019)

The magnetic susceptibility effect of gadolinium-based contrast agents on PRFS-based MR thermometry during thermal interventions
por: Hijnen, Nicole M, et al.
Publicado: (2013)

Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations
por: Granata, Vincenza, et al.
Publicado: (2016)

Addition of gadolinium contrast to three-dimensional SSFP MR sequences improves the visibility of coronary artery anatomy in young children
por: Shen, Quanli, et al.
Publicado: (2023)

Can gadolinium contrast agents be replaced with saline for direct MR arthrography of the hip? A pilot study with arthroscopic comparison
por: Meier, Malin K., et al.
Publicado: (2023)

An initial investigation of serum cytokine levels in patients with gadolinium retention
por: Maecker, Holden T., et al.
Publicado: (2020)

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer
por: Lancelot, Eric, et al.
Publicado: (2020)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval
por: Kwon, Chiheon, et al.
Publicado: (2021)

An experimental phantom study of the effect of gadolinium-based MR contrast agents on PET attenuation coefficients and PET quantification in PET-MR imaging: application to cardiac studies
por: O’ Doherty, Jim, et al.
Publicado: (2017)

Preparation and In Vitro Evaluation of a Gadolinium-Containing Vitamin E TPGS Micelle as a Potential Contrast Agent for MR Imaging
por: Gai, Yongkang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0vnjoffvqb03gms3mu2o105c4